Antidepressants are first-line treatments for major depressive disorder, but 40-60% of patients will not respond to treatment. This study independently replicates machine learning methodology predicting antidepressant outcomes using the STAR*D dataset and then externally validates these methods using the CAN-BIND-1 dataset, finding successful replication with similar prediction performance across databases.
This replication and external validation study demonstrates that machine learning methods can successfully predict antidepressant treatment outcomes, with prediction of remission performing better than prediction of response. These findings support the clinical utility of machine learning approaches for personalized depression treatment planning.